Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : MEDX ... anybody following? -- Ignore unavailable to you. Want to Upgrade?

To: tuck who wrote (2175)	6/23/2009 11:31:43 AM
From: scaram(o)uche	Read Replies (1) \| Respond to of 2240

Wow, it's only two patients! Wow, it wasn't MAb alone! These are insights that Lowe has in common with any second grader, and his blog has nothing else to contribute. If you do pubmeds on "Blute ML" and "Kwon ED", you'll see that something NEW to them isn't the same as something new in prostate surgery to Lowe, who has never picked up a scalpel to address a PATIENT in his entire cheap-shot life. Disclosure..... I have very, very few shares of MEDX, given that I expect dramatic success with any cancer vaccine to be hidden among failures of the same vaccine. As anyone and everyone at SI knows, I expect the majority of spontaneous cancers to be non-immunogenic. I therefore have very little interest, other than an academic one, in the success of MEDX. But I'm praying for ipi, and Lowe should be as well. In this case, he has nothing to contribute and has shown a lack of respect for those with tons relevant experience.